REG - Animalcare Group PLC - Result of 2024 AGM and Board Changes

AnimalcareAnnouncement

20/06/2024 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240620:nRST2838Ta&default-theme=true

RNS Number : 2838T  Animalcare Group PLC  20 June 2024

 

Animalcare Group plc

(''Animalcare'', "the Company" or "the Group")

 

Result of 2024 AGM and Board Changes

 

20 June 2024. As announced on 9 April 2024 by Animalcare Group plc (AIM:
ANCR), at the conclusion of today's Annual General Meeting ("AGM"), Jan Boone
stepped down from the Board and Ed Torr, previously Senior Independent
Director, succeeded Jan as Chair. The Board has also reviewed the composition
of its Committees and agreed that Sylvia Metayer will take on the role of
Senior Independent Director and Dr Doug Hutchens will chair the Remuneration
& Nomination Committee. These changes take place with immediate effect.

Animalcare Group plc confirms that all the resolutions put to the AGM today
were duly passed.  All resolutions were decided on a poll.  Resolutions 1 to
12 were passed as ordinary resolutions and resolutions 13 to 15 were passed as
special resolutions. The voting results are given below.

 

 No  Resolution                                                                      Votes FOR (including discretionary)  %        Votes AGAINST  %      % of ISC Voted  Votes WITHHELD
 1   To receive the audited annual accounts of the Company for the year ended 31     44,622,675                           100.00%   -             0.00%  73.91%           -
     December 2023 together with the directors' report and the auditors' report on
     those annual accounts.
 2   To declare a final dividend for the year ended 31 December 2023 of 3.0 pence    44,622,675                           100.00%   -             0.00%  73.91%           -
     per ordinary share.
 3   To re-elect Mr C Brewster as a Director.                                        44,621,725                           100.00%   -             0.00%  73.91%           950
 4   To re-elect Mr M Coucke as a Director.                                           44,621,725                          100.00%   -             0.00%  73.91%           950
 5   To re-elect Dr D Hutchens as a Director.                                         44,621,725                          100.00%   -             0.00%  73.91%           950
 6   To re-elect Ms S Metayer as a Director.                                          44,621,725                          100.00%   -             0.00%  73.91%           950
 7   To re-elect Mr E Torr as a Director.                                             44,551,296                          99.84%    70,429        0.16%  73.91%           950
 8   To re-elect Ms J Winter as a Director                                            44,621,725                          100.00%   -             0.00%  73.91%           950
 9   To approve the Directors' Remuneration Report as set out in the Annual Report    44,621,725                          100.00%   -             0.00%  73.91%           950
     and Accounts 2023.
 10  To approve the appointment of Grant Thornton UK LLP as auditors of the           44,619,725                          100.00%   2,000         0.00%  73.91%           950
     Company.
 11  To authorise the Audit and Risk Committee to determine the remuneration of the   44,619,725                          100.00%   2,000         0.00%  73.91%           950
     auditors.
 12  To authorise the Directors to allot shares.                                      41,320,968                          92.60%    3,301,707     7.40%  73.91%           -
 13  To authorise the Directors to disapply statutory pre-emption rights in respect   44,598,175                          100.00%   2,000         0.00%  73.87%           22,500
     of the Company's issued share capital.
 14  To authorise the Directors to disapply pre-emption rights for purposes of        41,320,968                          92.60%    3,301,707     7.40%  73.91%           -
     acquisitions or capital investments.
 15  To authorise the Company to purchase its own shares.                            44,622,675                           100.00%   -             0.00%  73.91%           -

 

Notes:

1. Any proxy arrangement which gave discretion to the Chairman has been
included in the "For" totals.

2. A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against" any
resolution.

3. The number of shares in issue at 11.30am on 18 June 2024 was 60,374,268
("ISC"). Holders of ordinary shares are entitled to one vote per share. No
shares are held in treasury.

 Enquiries:

 Animalcare Group Plc                      +44 (0)1904 487 687

 Chris Brewster, Chief Financial Officer   communications@animalcaregroup.com

and Company Secretary
 Stifel Nicolaus Europe Limited            +44 (0)20 7710 7600

 (Nominated Advisor & Joint Broker)

 Ben Maddison

 Nicholas Harland

 Francis North
 Panmure Gordon                            +44 (0)20 7886 2500

 (Joint Broker)

 Corporate Finance

 Freddy Crossley/Emma Earl

 Corporate Banking

 Rupert Dearden

 

About Animalcare

Animalcare Group plc is a UK AIM-listed international
development-focused veterinary sales and marketing organisation. Animalcare
operates in seven countries and exports to approximately 40 countries in
Europe and worldwide. The Group is focused on bringing new and innovative
products to market through its own development pipeline, partnerships and via
acquisition.

For more information about Animalcare, please visit www.animalcaregroup.com
(http://www.animalcaregroup.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGKZGZVKGKGDZM